Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Betamethason und Calcipotriol in allen Darreichungsformen, ausgenommen Salben und Gele (ATC-Code: D05AX22).

Conclusion of a non-exclusive rebate contract pursuant to § 130a para. 8 SGB V for medicinal products with the active substance combination of betamethasone and calcipotriol in all dosage forms, except for ointments and gels (ATC code: D05AX22) within the period from 01.05.2026 to 30.04.2028 with the possibility of concluding the contract at any time during the term ("open-house model").